Category:Parkinson's disease

• Parkinson's disease

A

• A-77636
• Adaptive Deep Brain Stimulation
• Alpha synuclein
• AMI-193
• Anti-parkinson drug
• Antiparkinsonian
• Antiparkinsonian agents
• ATP13A2

B

• Benserazide
• Blarcamesine
• BOMT
• Braak staging

C

• Carbidopa/oxitriptan
• Catechol-O-methyltransferase inhibitor
• Causes of Parkinson's disease
• Cell-based therapies for Parkinson's disease
• Clobenztropine
• COMT inhibitor
• CY-208,243

D

• D2 receptor
• DaT scan
• ΔFosB
• Dexetimide
• DMT1
• Dopa
• Dopamine dysregulation syndrome
• Drug-induced parkinsonism

E

• Early-onset parkinsonism-intellectual disability syndrome
• Endoplasmic Reticulum
• Ethopropazine hydrochloride
• Etybenzatropine

F

• Festination
• FG-8205
• Foliglurax
• Frontotemporal dementia and parkinsonism linked to chromosome 17

H

• Hoehn and Yahr scale

I

• Ioflupane (123I)

K

• Kemadrin
• KNT-127

L

• L-dopa
• L-Dopa
• Ladostigil
• Larodopa
• Lazabemide
• LBT-3627
• Lergotrile
• Levodopa/benserazide
• Lewy
• Lewy bodies
• Lewy body
• Lewy body dementias
• List of people diagnosed with Parkinson's disease
• LRRK2
• LY-393558

M

• Mazaticol
• Metixene
• MPP+
• MPTP
• Myerson's sign

N

• Nitecapone

O

• Octopamine
• Orphenadrine citrate

P

• Pallidotomy
• Paralysis agitans
• Pardoprunox
• PARK2
• PARK7
• Parkin
• Parkin (protein)
• Parkinson disease 2
• Parkinson's Disease
• Parkinson's disease dementia
• Parkinson's Foundation
• Parkinson's UK
• Parkinson-plus syndrome
• Parkinsonian gait
• Parkinsonism
• Pathophysiology of Parkinson's disease
• Piclozotan
• PINK1
• Piribedil
• Post-encephalitic parkinsonism
• Postencephalitic parkinsonism
• Procerus sign
• Procyclidine
• ProSavin

R

• Remacemide
• Remeglurant
• Rigidity
• Rivastigmine tartrate

S

• Salsolinol
• Sarizotan
• Sergolexole
• SIB-1508Y
• Signs and symptoms of Parkinson's disease
• SKF-77,434
• SKF-83959
• Stepholidine
• Substantia nigra

T

• Talipexole
• Thalamotomy
• Tremorine

U

• Unified

V

• Vanoxerine

W

• World Parkinson Congress